AIM: To examine medical and lifestyle preventive behaviors among women with varying levels of familial breast cancer risk. METHODS: Using cross-sectional data from the Minnesota Breast Cancer Family Study, a historical cohort of 426 families, we compared medical (mammography adherence, antiestrogen use, and prophylactic surgery) and lifestyle (physical activity, smoking, alcohol, and diet) behaviors across three groups of cancer-free women ages 18 to 95 defined by their family history of breast cancer. Family history was classified as high-risk, moderate-risk, or average to low-risk depending on the number and degree of relationship of family members with breast cancer. RESULTS: After adjusting for age and education, high-risk women were twice as likely to have ever used an antiestrogenic agent (9.0% versus 4.6% among moderate-risk and 4.1% among average to low-risk; P = 0.002). Among women ages <40, the high-risk group were more likely to have ever had a mammogram (82% versus 47% among moderate-risk and 35% among average to low-risk; P < 0.001). Average to low-risk women were the least likely to be current smokers and high-risk women may consume slightly fewer fruits and vegetables compared with the other groups, but there were no other differences in lifestyle behaviors, including physical activity and alcohol use. CONCLUSIONS: Women with strong family histories of breast cancer are more likely to undertake medical but not lifestyle preventive behaviors.
AIM: To examine medical and lifestyle preventive behaviors among women with varying levels of familial breast cancer risk. METHODS: Using cross-sectional data from the Minnesota Breast Cancer Family Study, a historical cohort of 426 families, we compared medical (mammography adherence, antiestrogen use, and prophylactic surgery) and lifestyle (physical activity, smoking, alcohol, and diet) behaviors across three groups of cancer-free women ages 18 to 95 defined by their family history of breast cancer. Family history was classified as high-risk, moderate-risk, or average to low-risk depending on the number and degree of relationship of family members with breast cancer. RESULTS: After adjusting for age and education, high-risk women were twice as likely to have ever used an antiestrogenic agent (9.0% versus 4.6% among moderate-risk and 4.1% among average to low-risk; P = 0.002). Among women ages <40, the high-risk group were more likely to have ever had a mammogram (82% versus 47% among moderate-risk and 35% among average to low-risk; P < 0.001). Average to low-risk women were the least likely to be current smokers and high-risk women may consume slightly fewer fruits and vegetables compared with the other groups, but there were no other differences in lifestyle behaviors, including physical activity and alcohol use. CONCLUSIONS:Women with strong family histories of breast cancer are more likely to undertake medical but not lifestyle preventive behaviors.
Authors: Ki Young Son; Sang Min Park; Chi Hoon Lee; Geum Jeong Choi; DaeGeun Lee; SeoungHee Jo; Se Hoon Lee; BeLong Cho Journal: Support Care Cancer Date: 2010-05-06 Impact factor: 3.603
Authors: Jung Min Kang; Dong Wook Shin; Young Min Kwon; Sang Min Park; Min Sun Park; Jin Ho Park; Ki Young Son; Be Long Cho Journal: World J Gastroenterol Date: 2011-08-14 Impact factor: 5.742
Authors: Heather Greenlee; Christine L Sardo Molmenti; Laura Falci; Ross Ulmer; Sandra Deming-Halverson; Lisa A DeRoo; Dale P Sandler Journal: Breast Cancer Res Treat Date: 2016-03-26 Impact factor: 4.872
Authors: Traci N Bethea; Lynn Rosenberg; Nelsy Castro-Webb; Kathryn L Lunetta; Lara E Sucheston-Campbell; Edward A Ruiz-Narváez; Marjory Charlot; Song-Yi Park; Elisa V Bandera; Melissa A Troester; Christine B Ambrosone; Julie R Palmer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-31 Impact factor: 4.254
Authors: Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude Journal: Fam Cancer Date: 2013-06 Impact factor: 2.375
Authors: Evelinn A Borrayo; Lisa Hines; Tim Byers; Betsy Risendal; Martha L Slattery; Carol Sweeney; Kathy B Baumgartner; Anna Giuliano Journal: J Womens Health (Larchmt) Date: 2009-10 Impact factor: 2.681
Authors: Cynthia D Myers; Paul B Jacobsen; Yifan Huang; Marlene H Frost; Christi A Patten; James R Cerhan; Thomas A Sellers Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-06-09 Impact factor: 4.254
Authors: Ellen T Chang; Roger L Milne; Kelly-Anne Phillips; Jane C Figueiredo; Meera Sangaramoorthy; Theresa H M Keegan; Irene L Andrulis; John L Hopper; Pamela J Goodwin; Frances P O'Malley; Nayana Weerasooriya; Carmel Apicella; Melissa C Southey; Michael L Friedlander; Graham G Giles; Alice S Whittemore; Dee W West; Esther M John Journal: Breast Cancer Res Treat Date: 2008-11-26 Impact factor: 4.872